Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma

NCT00937183 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine
BIOLOGICAL: autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine
BIOLOGICAL: autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine

Sponsor

Jan Walewski